Ditchcarbon
  • Customers
  1. Organizations
  2. Molnlycke
Public Profile
Pharmaceutical Preparation Manufacturing
SE
updated 25 days ago

Molnlycke

Company website

Mölnlycke Health Care, commonly referred to as Mölnlycke, is a leading global provider of wound care and surgical solutions, headquartered in Sweden (SE). Founded in 1849, the company has established a strong presence in Europe, North America, and Asia, focusing on innovative products that enhance patient outcomes. Mölnlycke is renowned for its advanced wound care products, including the Mepilex® range of foam dressings and the Safetac® technology, which minimises pain during dressing changes. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, achieving notable milestones such as ISO certification and recognition for its sustainability efforts. With a robust market position, Mölnlycke continues to lead the industry by prioritising patient safety and comfort, making significant contributions to the fields of wound management and surgical care.

DitchCarbon Score

How does Molnlycke's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Molnlycke's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Molnlycke's reported carbon emissions

In 2024, Mölnlycke Health Care reported total carbon emissions of approximately 549,129,000 kg CO2e. This includes Scope 1 emissions of about 52,356,000 kg CO2e, Scope 2 emissions of approximately 10,513,000 kg CO2e (market-based), and a significant contribution from Scope 3 emissions, which totalled around 486,261,000 kg CO2e. The Scope 3 emissions breakdown reveals major sources such as purchased goods and services (approximately 312,323,000 kg CO2e) and upstream transportation and distribution (about 41,254,000 kg CO2e). In 2023, the company reported total emissions of about 519,117,000 kg CO2e, with Scope 1 at approximately 52,788,000 kg CO2e, Scope 2 at around 20,276,000 kg CO2e (market-based), and Scope 3 emissions at about 446,053,000 kg CO2e. This indicates a slight increase in total emissions from 2023 to 2024. Mölnlycke has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 GHG emissions by 50% by 2030, using 2021 as the baseline year. Additionally, the company plans to increase its sourcing of renewable electricity from 23% in 2021 to 100% by the end of 2024 and maintain this level through 2030. For Scope 3 emissions, Mölnlycke targets a 20% reduction by 2028 from the same baseline year. Long-term goals include achieving net-zero emissions across the value chain by 2050, with specific targets of reducing Scope 1 and 2 emissions by 90% and Scope 3 emissions by 97% per ton of sold product by 2050. These targets align with the Science Based Targets initiative (SBTi) and reflect the company's commitment to sustainable practices in the healthcare sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021202220232024
Scope 1
41,653,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
52,743,000
00,000,000
-
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
00,000,000
000,000
000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Molnlycke's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Molnlycke is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Molnlycke is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 43 minutes ago

Abena A Slash S

DK
•
Paper and paper products
Updated 5 days ago

Hogy Medical Co.,Ltd.

JP
•
Health and social work services (85)
Updated 5 days ago

Cardinal Health

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Mercator Medical S.A.

PL
•
Health and social work services (85)
Updated 5 days ago

Paul Hartmann AG

DE
•
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250821.7
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy